Skip to content
 
Search

Latest Stories

GPhC tightens rules for online obesity drug prescriptions

Obesity drug
Boxes of Wegovy are seen at a pharmacy in London. (Photo: Reuters)
Eastern Eye
By Eastern EyeFeb 04, 2025
Eastern Eye

See Full Bio

The General Pharmaceutical Council (GPhC), which oversees UK pharmacies, has introduced stricter rules for online pharmacies prescribing obesity drugs. The regulator said the changes aim to prevent individuals from receiving medicines that could pose health risks.

The new guidance, updated for the first time in three years, follows concerns about how some online pharmacies dispense weight-loss drugs.

The GPhC has also added GLP-1 receptor agonists, including weight-loss injections Wegovy and Mounjaro, to its list of "high-risk medicines."

These drugs will now require extra safeguards when prescribed, similar to opioids, sedatives, antibiotics, and medicines for long-term conditions like asthma and diabetes.

Demand for obesity drugs in the UK has grown significantly. Last year, several online pharmacies estimated that around 500,000 people were using these medications through the private market, surpassing the number receiving them via the state-run National Health Service (NHS).

"We have seen, through our inspections and concerns raised by the public, some concerning ways in which these drugs were being supplied online and we have taken action as a result," said Louise Edwards, Chief Strategy Officer at the GPhC.

Since 2021, the regulator has taken enforcement action against at least a dozen online pharmacies over their supply of weight-loss medicines, Edwards said.

Under the updated rules, online pharmacies must now "independently verify the person's weight, height, and/or body mass index" before prescribing obesity drugs.

This can be done through a video consultation, reviewing clinical records, or contacting the person's doctor. Online questionnaires and phone calls will no longer be considered sufficient for verification.

Wegovy is produced by Danish pharmaceutical company Novo Nordisk, while Mounjaro is made by US-based Lilly. Both companies have seen significant profits from their weight-loss drugs.

In December, the World Health Organization said these medications, alongside other health measures, could play a role in addressing the global obesity crisis.

diabetesgeneral pharmaceutical councilgphcmounjaroobesity drug prescriptionsobesity drugsonline pharmaciesuk pharmacieswegovyweightloss drugsozempic uk

Related News

Navratri festival in Wembley
UK

Navratri festival in Wembley faces objections

Priyanka Chopra
Entertainment

Priyanka Chopra shuts down criticism after choosing hot dog over vada pav in viral video

Bianca Censori
Entertainment

Bianca Censori poses nearly nude in photos taken by Kanye West raising fresh questions about control

SBI UK cuts mortgage rates
Business

SBI UK cuts mortgage rates

More For You

Barbie with type 1 diabetes

This is also part of Mattel’s mission to extend the boundaries of imaginative play

Mattel

Mattel introduces first Barbie doll with type 1 diabetes to promote inclusion

Highlights

  • Mattel launches new Barbie with type 1 diabetes
  • The doll features a glucose monitor, insulin pump and CGM app
  • Created in collaboration with type 1 diabetes charity Breakthrough T1D
  • Part of Mattel’s broader push for inclusivity and representation in toys

Barbie with type 1 diabetes joins inclusive fashionistas range

Mattel has launched its first diabetes Barbie doll, designed to represent children with type 1 diabetes and promote greater inclusivity in children’s toys.

The new addition to the Barbie Fashionistas line comes with realistic medical features including a continuous glucose monitor (CGM) on her arm, secured with heart-shaped medical tape, and an insulin pump to help manage her blood sugar levels. She also carries a smartphone with a CGM app to monitor glucose throughout the day, and a bag large enough to store snacks and other essentials.

Keep ReadingShow less
Gemma Collins Instagram ban

Collins accepted the findings of the ASA’s investigation

Getty Images

Gemma Collins’ Instagram post banned over weight-loss drug promotion

Highlights

  • Instagram post by Gemma Collins promoting Yazen weight-loss service banned
  • ASA rules it breached regulations on promoting prescription-only medication
  • Eight other weight-loss ads also banned in regulatory crackdown

ASA bans Collins' Instagram advert

An Instagram post by TV personality Gemma Collins promoting a weight-loss drug and digital service has been banned by the UK’s advertising watchdog for breaching regulations around prescription-only medicines.

Collins had shared a promotional video on 6 January 2025, stating: “I’m starting this year two sizes down, thanks to Yazen’s weight loss app and medication.” The Advertising Standards Authority (ASA) ruled that the post unlawfully promoted prescription-only medication to the public.

Keep ReadingShow less
New Covid strain

Experts have raised concerns about the immune-evasive nature of the Stratus strain

iStock

New Covid strain Stratus spreads in UK with unusual hoarse voice symptom

Key points

  • A new Covid strain known as Stratus is spreading across the UK
  • The variant is marked by a distinctive symptom: a hoarse or raspy voice
  • Sub-variants XFG and XFG.3 now account for 30% of cases in England
  • Experts say there is no evidence of more severe disease
  • Lower immunity levels may make more people vulnerable to infection

Covid variant Stratus on the rise in the UK

A new strain of Covid-19, known as Stratus, is spreading across the UK and drawing attention for its unusual symptom — a hoarse or raspy voice. According to data from the UK Health Security Agency (UKHSA), Stratus and its two sub-variants, XFG and XFG.3, are responsible for around 30 per cent of Covid cases in England.

Of the two, XFG.3 is currently the more dominant. The UKHSA confirmed that monitoring of all circulating Covid-19 variants is ongoing as part of regular surveillance.

Keep ReadingShow less
Human brain continues forming neurons

Neurogenesis, the process by which new neurons form in the brain

iStock

Human brain continues forming neurons well into old age, study finds

Key points

  • New neurons continue forming in the brain’s hippocampus into old age
  • Study confirms presence of neural progenitor cells in adults
  • DNA carbon dating and single-nucleus RNA sequencing were used
  • Research shows variation in neuron production between individuals
  • Findings could aid treatments for neurodegenerative and psychiatric disorders

Human brain shows ongoing neuron formation into older age

A new study has confirmed that the human brain continues to produce new nerve cells well into late adulthood, challenging previous assumptions about age-related decline in neurogenesis. The findings, published in the journal Science, provide fresh insight into how adaptable the brain remains over a lifetime.

Neurogenesis, the process by which new neurons form in the brain, is known to occur in the hippocampus — a region involved in memory. While previous research has suggested that this process continues throughout life, there has been limited concrete evidence of the presence of neural progenitor cells in the adult brain.

Keep ReadingShow less
Black women cancer risk

Serious public health challenges in the decades ahead

iStock

Study warns of rising uterine cancer rates, with Black women hardest hit

Key points

  • Uterine cancer cases and deaths are projected to rise significantly in the US by 2050.
  • Black women are expected to experience the highest increase in incidence-based mortality.
  • A new model predicts incidence rising to 86.9 cases per 100,000 for Black women and 74.2 for White women.
  • Researchers stress the urgent need for improved prevention and early detection strategies.

Sharp increase in uterine cancer predicted over next three decades

Uterine cancer, currently the fourth most commonly diagnosed cancer among women in the United States, is projected to see a substantial rise in both cases and deaths by 2050, particularly among Black women. A new study led by researchers at Columbia University warns of worsening racial disparities in outcomes if preventative measures are not introduced.

This year alone, around 69,120 new cases of uterine cancer and nearly 14,000 deaths are expected in the United States. However, projections by the Columbia University research team, published in Cancer Epidemiology, Biomarkers & Prevention, indicate a significant increase in both incidence and mortality over the next 30 years.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Asian Media Group USA Inc